Colinz Laboratories Limited (COLINZ.BO)
INR 52.06
(-4.07%)
INR 52.06
(-4.07%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -64.3 Million INR | -280.04% |
| 2022 | -16.92 Million INR | -5.51% |
| 2021 | -16.03 Million INR | -298.91% |
| 2020 | -4.02 Million INR | -1102.3% |
| 2019 | -334.35 Thousand INR | -108.35% |
| 2018 | 4 Million INR | 142.73% |
| 2017 | 1.64 Million INR | -53.05% |
| 2016 | 3.51 Million INR | -9.18% |
| 2015 | 3.86 Million INR | -30.24% |
| 2014 | 5.54 Million INR | -18.4% |
| 2013 | 6.79 Million INR | -48.4% |
| 2012 | 13.17 Million INR | -10.16% |
| 2011 | 14.65 Million INR | -12.49% |
| 2010 | 16.75 Million INR | -31.94% |
| 2009 | 24.61 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -30.52 Million INR | -143.6% |
| 2024 Q1 | 70 Million INR | 208.86% |
| 2023 Q2 | -20.2 Million INR | -135.27% |
| 2023 Q1 | 57.28 Million INR | 438.58% |
| 2023 FY | -64.3 Million INR | -280.04% |
| 2023 Q3 | 63.47 Million INR | 414.1% |
| 2023 Q4 | -64.3 Million INR | -201.31% |
| 2022 Q3 | - INR | 100.0% |
| 2022 Q2 | -19.46 Million INR | -137.39% |
| 2022 FY | -16.92 Million INR | -5.51% |
| 2022 Q1 | 52.06 Million INR | 424.67% |
| 2022 Q4 | -16.92 Million INR | 0.0% |
| 2021 Q3 | 52.68 Million INR | 606.61% |
| 2021 Q1 | 46.81 Million INR | 1264.53% |
| 2021 Q4 | -16.03 Million INR | -130.44% |
| 2021 Q2 | -10.4 Million INR | -122.22% |
| 2021 FY | -16.03 Million INR | -298.91% |
| 2020 Q1 | 25.97 Million INR | 7869.79% |
| 2020 Q3 | 39.79 Million INR | 540.5% |
| 2020 Q2 | -9.03 Million INR | -134.77% |
| 2020 Q4 | -4.02 Million INR | -110.1% |
| 2020 FY | -4.02 Million INR | -1102.3% |
| 2019 Q1 | 19.92 Million INR | 397.77% |
| 2019 Q3 | 20.61 Million INR | 171691.66% |
| 2019 Q4 | -334.35 Thousand INR | -101.62% |
| 2019 Q2 | 12 Thousand INR | -99.94% |
| 2019 FY | -334.35 Thousand INR | -108.35% |
| 2018 FY | 4 Million INR | 142.73% |
| 2018 Q2 | 6.25 Million INR | -66.57% |
| 2018 Q1 | 18.69 Million INR | 1033.64% |
| 2018 Q4 | 4 Million INR | -78.06% |
| 2018 Q3 | 18.24 Million INR | 191.92% |
| 2017 Q1 | 16.33 Million INR | 365.05% |
| 2017 Q2 | -6.47 Million INR | -139.6% |
| 2017 FY | 1.64 Million INR | -53.05% |
| 2017 Q4 | 1.64 Million INR | 0.0% |
| 2016 Q3 | 18.46 Million INR | 901.95% |
| 2016 FY | 3.51 Million INR | -9.18% |
| 2016 Q4 | 3.51 Million INR | -80.97% |
| 2016 Q2 | -2.3 Million INR | -114.24% |
| 2016 Q1 | 16.16 Million INR | 8062.93% |
| 2015 FY | 3.86 Million INR | -30.24% |
| 2015 Q4 | -203 Thousand INR | -101.27% |
| 2015 Q3 | 15.98 Million INR | 419.84% |
| 2015 Q2 | 3.07 Million INR | -82.68% |
| 2015 Q1 | 17.75 Million INR | 220.16% |
| 2014 Q1 | 12.01 Million INR | 76.77% |
| 2014 FY | 5.54 Million INR | -18.4% |
| 2014 Q4 | 5.54 Million INR | -48.55% |
| 2014 Q3 | 10.77 Million INR | 87.82% |
| 2014 Q2 | 5.73 Million INR | -52.24% |
| 2013 Q4 | 6.79 Million INR | -34.22% |
| 2013 FY | 6.79 Million INR | -48.4% |
| 2013 Q3 | 10.33 Million INR | 0.82% |
| 2013 Q1 | 9.38 Million INR | -28.75% |
| 2013 Q2 | 10.24 Million INR | 9.2% |
| 2012 FY | 13.17 Million INR | -10.16% |
| 2012 Q4 | 13.17 Million INR | 0.0% |
| 2011 Q4 | 14.65 Million INR | 0.0% |
| 2011 FY | 14.65 Million INR | -12.49% |
| 2010 FY | 16.75 Million INR | -31.94% |
| 2009 FY | 24.61 Million INR | 0.0% |
| 2009 Q4 | 24.61 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.21 Million INR | 355.036% |
| Sastasundar Ventures Limited | -297.24 Million INR | 78.367% |
| KIMIA BIOSCIENCES LIMITED | 431.72 Million INR | 114.894% |
| SHELTER PHARMA LIMITED | -44.62 Million INR | -44.1% |
| Vasundhara Rasayans Limited | -76.15 Million INR | 15.561% |
| Sunil Healthcare Limited | 625.4 Million INR | 110.282% |
| Chemo Pharma Laboratories Limited | -6.05 Million INR | -961.456% |
| MedPlus Health Services Limited | 8.67 Billion INR | 100.741% |
| Zenith Healthcare Limited | -25.45 Million INR | -152.595% |
| Patidar Buildcon Limited | 25.12 Million INR | 355.922% |
| Sanjivani Paranteral Limited. | -85.95 Million INR | 25.186% |
| Smruthi Organics Limited | 111.28 Million INR | 157.78% |
| Trident Lifeline Limited | 117.56 Million INR | 154.698% |
| Bacil Pharma Limited | 569 Thousand INR | 11401.054% |
| Pharmaids Pharmaceuticals Limited | 37.28 Million INR | 272.45% |
| Gujarat Terce Laboratories Limited | 37.76 Million INR | 270.276% |
| Sandu Pharmaceuticals Limited | -11.43 Million INR | -462.581% |
| Tyche Industries Limited | -788.94 Million INR | 91.849% |
| Trimurthi Limited | -1.17 Million INR | -5357.732% |
| Zenlabs Ethica Limited | 139.54 Million INR | 146.08% |
| Vikram Thermo (India) Limited | 38.62 Million INR | 266.48% |
| ANG Lifesciences India Limited | 671.01 Million INR | 109.583% |
| Parmax Pharma Limited | 51.8 Million INR | 224.113% |
| Deccan Health Care Limited | -7.07 Million INR | -808.748% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 106.142% |
| Makers Laboratories Limited | 172.59 Million INR | 137.257% |
| Lactose (India) Limited | 373.97 Million INR | 117.195% |
| Bharat Immunologicals & Biologicals Corporation Limited | 689.39 Million INR | 109.328% |
| Roopa Industries Limited | 216.01 Million INR | 129.768% |
| PANJON LTD. | -12.8 Million INR | -402.053% |
| TIAAN CONSUMER LIMITED | 13.44 Million INR | 578.267% |
| Anuh Pharma Limited | -69.8 Million INR | 7.885% |
| Crestchem Limited | -1.45 Million INR | -4334.69% |
| Emmessar Biotech & Nutrition Limited | -60.73 Million INR | -5.88% |
| Mercury Laboratories Limited | -26.72 Million INR | -140.574% |
| PRAVEG LIMITED | -434.98 Million INR | 85.217% |
| Fredun Pharmaceuticals Limited | 1.04 Billion INR | 106.159% |
| Shukra Pharmaceuticals Limited | -68.26 Million INR | 5.804% |
| Norris Medicines Limited | 214.86 Million INR | 129.928% |
| Denis Chem Lab Limited | -236.28 Million INR | 72.786% |
| Veerhealth Care Limited | -2.38 Million INR | -2596.143% |
| Kwality Pharmaceuticals Limited | 921.75 Million INR | 106.976% |
| Jenburkt Pharmaceuticals Limited | -791.91 Million INR | 91.88% |
| OXYGENTA PHARMACEUTICAL LIMITE | 571.32 Million INR | 111.255% |
| Godavari Drugs Limited | 530.02 Million INR | 112.132% |
| SHAMROCK INDUSTRIAL CO.LTD. | -9.31 Million INR | -590.687% |
| Zenotech Laboratories Limited | -196.85 Million INR | 67.335% |
| Panchsheel Organics Limited | -157.82 Million INR | 59.256% |
| Ambalal Sarabhai Enterprises Limited | 132.1 Million INR | 148.678% |
| Gennex Laboratories Limited | -552.54 Million INR | 88.362% |
| Vivanza Biosciences Limited | 50.02 Million INR | 228.539% |
| Phaarmasia Limited | -4.89 Million INR | -1213.11% |
| Medi-Caps Limited | -3.21 Million INR | -1900.716% |
| DECIPHER LABS LIMITED | -93.13 Million INR | 30.959% |
| Shree Ganesh Remedies Limited | 201.85 Million INR | 131.856% |
| Gujarat Themis Biosyn Limited | -53.88 Million INR | -19.336% |
| Bharat Parenterals Limited | 1.48 Billion INR | 104.319% |
| BDH Industries Limited | -164.47 Million INR | 60.903% |
| Vista Pharmaceuticals Limited | 78.7 Million INR | 181.702% |
| Coral Laboratories Limited | -612.82 Million INR | 89.507% |
| Concord Drugs Limited | 164.48 Million INR | 139.093% |
| Beryl Drugs Limited | 48.7 Million INR | 232.017% |
| Evoq Remedies Limited | 41.14 Million INR | 256.272% |
| Add-Shop E-Retail Limited | 116.24 Million INR | 155.315% |
| Transchem Limited | -3.16 Million INR | -1932.975% |
| Ishita Drugs and Industries Limited | -48.09 Million INR | -33.692% |
| Parnax Lab Limited | 787.61 Million INR | 108.164% |
| Source Natural Foods and Herbal Supplements Limited | -58.58 Million INR | -9.758% |
| Kerala Ayurveda Limited | 447.82 Million INR | 114.359% |
| Cian Healthcare Limited | 544.97 Million INR | 111.799% |
| Trinity League India Limited | -12 Thousand INR | -535758.333% |
| Syschem (India) Limited | 3.53 Million INR | 1920.583% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 104.609% |
| Natural Capsules Limited | 956.68 Million INR | 106.721% |
| Auro Laboratories Limited | 252.51 Million INR | 125.465% |